CORC  > 复旦大学上海医学院
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study
Shi, Tingyan; Jiang, Rong; Pu, Hong; Yang, Huijuan; Tu, Dongsheng; Dai, Zhiyuan; Cai, Yunlang; Zhang, Yuqin; Cheng, Xi; Jia, Huixun
刊名BRITISH JOURNAL OF CANCER
2019
卷号121期号:5
ISSN号0007-0920
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3595919
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Shi, Tingyan,Jiang, Rong,Pu, Hong,et al. Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study[J]. BRITISH JOURNAL OF CANCER,2019,121(5).
APA Shi, Tingyan.,Jiang, Rong.,Pu, Hong.,Yang, Huijuan.,Tu, Dongsheng.,...&Zang, Rongyu.(2019).Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.BRITISH JOURNAL OF CANCER,121(5).
MLA Shi, Tingyan,et al."Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study".BRITISH JOURNAL OF CANCER 121.5(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace